PharmacoEconomics and Outcomes News via MedWorm.com MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'PharmacoEconomics and Outcomes News' source. Sat, 20 Mar 2010 15:50:49 +0100 Acorda Therapeutics' have established patient support services to assist with the costs of their new multiple sclerosis (MS) treatment Ampyra http://www.medworm.com/index.php?rid=3293748&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00033 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293748 Mon, 22 Feb 2010 16:24:07 +0100 3293748 Systemic psoriasis therapy costs are increasing at a much higher rate compared with general inflation http://www.medworm.com/index.php?rid=3293747&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00032 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293747 Mon, 22 Feb 2010 16:24:07 +0100 3293747 New York City's health department has launched the National Salt Reduction Initiative (NSRI). http://www.medworm.com/index.php?rid=3293746&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00031 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293746 Mon, 22 Feb 2010 16:24:07 +0100 3293746 Stroke strategy shows positive impact in England http://www.medworm.com/index.php?rid=3293745&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00030 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293745 Mon, 22 Feb 2010 16:24:07 +0100 3293745 The health of children under 5 years of age has not significantly improved since 1998 in England http://www.medworm.com/index.php?rid=3293744&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00029 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293744 Mon, 22 Feb 2010 16:24:07 +0100 3293744 The new, self-administered GERD-QOL is a "well-developed and validated instrument" http://www.medworm.com/index.php?rid=3293743&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00028 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293743 Mon, 22 Feb 2010 16:24:07 +0100 3293743 Routine ultrasound not needed in abortion follow-up care http://www.medworm.com/index.php?rid=3293742&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00027 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293742 Mon, 22 Feb 2010 16:24:07 +0100 3293742 Adding lapatinib improves QOL in breast cancer subgroup http://www.medworm.com/index.php?rid=3293741&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00026 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293741 Mon, 22 Feb 2010 16:24:07 +0100 3293741 Self-monitoring of blood glucose not worth it in Canada http://www.medworm.com/index.php?rid=3293740&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00025 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293740 Mon, 22 Feb 2010 16:24:07 +0100 3293740 Tailored approach to CAD looks good http://www.medworm.com/index.php?rid=3293739&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00024 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293739 Mon, 22 Feb 2010 16:24:07 +0100 3293739 Equally effective, a lot more expensive, but still cost saving? http://www.medworm.com/index.php?rid=3293738&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00023 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293738 Mon, 22 Feb 2010 16:24:07 +0100 3293738 Potentially inappropriate prescriptions raise costs http://www.medworm.com/index.php?rid=3293737&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00022 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293737 Mon, 22 Feb 2010 16:24:07 +0100 3293737 Noncost factors affect drug adherence rates in elderly http://www.medworm.com/index.php?rid=3293736&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00021 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293736 Mon, 22 Feb 2010 16:24:07 +0100 3293736 PCV7 potentially cost effective in Argentina http://www.medworm.com/index.php?rid=3293735&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00020 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293735 Mon, 22 Feb 2010 16:24:07 +0100 3293735 Pediatric vaccination costs exceed reimbursement http://www.medworm.com/index.php?rid=3293734&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00019 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293734 Mon, 22 Feb 2010 16:24:07 +0100 3293734 MARS a down-to-earth choice in acute liver failure http://www.medworm.com/index.php?rid=3293733&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00018 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293733 Mon, 22 Feb 2010 16:24:07 +0100 3293733 Which UTI management strategy best in the UK? http://www.medworm.com/index.php?rid=3293732&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00017 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293732 Mon, 22 Feb 2010 16:24:07 +0100 3293732 Reimbursement changes don't cut costs in bladder cancer http://www.medworm.com/index.php?rid=3293731&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00016 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293731 Mon, 22 Feb 2010 16:24:07 +0100 3293731 Antiretroviral adherence swings treatment costs in Africa http://www.medworm.com/index.php?rid=3293730&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00015 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293730 Mon, 22 Feb 2010 16:24:07 +0100 3293730 Adherence to prescribing advice leads to better outcomes http://www.medworm.com/index.php?rid=3293729&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00014 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293729 Mon, 22 Feb 2010 16:24:07 +0100 3293729 Combo therapy for 2 CHD prevention not uniform in the US http://www.medworm.com/index.php?rid=3293728&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00013 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293728 Mon, 22 Feb 2010 16:24:07 +0100 3293728 UNICEF fails to accelerate child survival in west Africa http://www.medworm.com/index.php?rid=3293727&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00012 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293727 Mon, 22 Feb 2010 16:24:07 +0100 3293727 Laser therapy elevates costs in POAG http://www.medworm.com/index.php?rid=3293726&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00011 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293726 Mon, 22 Feb 2010 16:24:07 +0100 3293726 FDA's ability to affect treatment patterns appears limited http://www.medworm.com/index.php?rid=3293725&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00010 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293725 Mon, 22 Feb 2010 16:24:07 +0100 3293725 S. aureus vaccine cost effective for orthopaedic patients http://www.medworm.com/index.php?rid=3293724&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00009 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293724 Mon, 22 Feb 2010 16:24:07 +0100 3293724 By 2013, Seroquel [quetiapine] and Seroquel XR (extended release) will account for nearly one quarter of the world's market http://www.medworm.com/index.php?rid=3293723&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00008 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293723 Mon, 22 Feb 2010 16:24:07 +0100 3293723 Cost sharing may have adverse consequences for elderly http://www.medworm.com/index.php?rid=3293722&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00007 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293722 Mon, 22 Feb 2010 16:24:07 +0100 3293722 The US Advisory Committee on Immunization Practices (ACIP) has released its recommended adult immunisation schedule for 2010. http://www.medworm.com/index.php?rid=3293721&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00006 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293721 Mon, 22 Feb 2010 16:24:07 +0100 3293721 Olmesartan prevents more cardiovascular complications http://www.medworm.com/index.php?rid=3293720&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00005 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293720 Mon, 22 Feb 2010 16:24:07 +0100 3293720 Oncology practices struggle under Medicare http://www.medworm.com/index.php?rid=3293719&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00004 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293719 Mon, 22 Feb 2010 16:24:07 +0100 3293719 Practice guidelines' worth disputed http://www.medworm.com/index.php?rid=3293718&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00003 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293718 Mon, 22 Feb 2010 16:24:07 +0100 3293718 South African study shows how few eligible patients start ART http://www.medworm.com/index.php?rid=3293717&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00002 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293717 Mon, 22 Feb 2010 16:24:07 +0100 3293717 Marmot Review lays out path to reducing health inequality http://www.medworm.com/index.php?rid=3293716&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000597%2Fart00001 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3293716 Mon, 22 Feb 2010 02:06:11 +0100 3293716 Research-based drug manufacturers in Ireland will cut prices by 40% for nearly 300 widely prescribed medicines http://www.medworm.com/index.php?rid=3250328&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00041 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250328 Mon, 08 Feb 2010 16:10:21 +0100 3250328 Three medicines have been accepted for use in Scotland by the Scottish Medicines Consortium http://www.medworm.com/index.php?rid=3250327&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00040 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250327 Mon, 08 Feb 2010 16:10:21 +0100 3250327 Small town drugstores are fearing collapse in Alberta, Canada, due to the provincial government's drug programme http://www.medworm.com/index.php?rid=3250326&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00039 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250326 Mon, 08 Feb 2010 16:10:21 +0100 3250326 The Japanese pharmaceutical market is expected to show stunted growth between 2010 and 2014 http://www.medworm.com/index.php?rid=3250325&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00038 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250325 Mon, 08 Feb 2010 16:10:21 +0100 3250325 The Chinese government intends on taking steps toward opening their drug market to Indian drug manufacturers http://www.medworm.com/index.php?rid=3250324&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00037 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250324 Mon, 08 Feb 2010 16:10:21 +0100 3250324 Telemedicine system fails to have positive impact in the ICU http://www.medworm.com/index.php?rid=3250323&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00036 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250323 Mon, 08 Feb 2010 16:10:21 +0100 3250323 Routine antidepressant management falls short of guideline recommendations, especially in primary care http://www.medworm.com/index.php?rid=3250322&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00035 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250322 Mon, 08 Feb 2010 16:10:21 +0100 3250322 Switch to mycophenolate sodium improves GI-related QOL http://www.medworm.com/index.php?rid=3250321&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00034 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250321 Mon, 08 Feb 2010 16:10:21 +0100 3250321 Indonesia will be requiring government doctors to prescribe generic drugs over branded drugs, wherever possible http://www.medworm.com/index.php?rid=3250320&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00033 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250320 Mon, 08 Feb 2010 16:10:21 +0100 3250320 Dementia research funding disproportionately low http://www.medworm.com/index.php?rid=3250319&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00032 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250319 Mon, 08 Feb 2010 16:10:21 +0100 3250319 Cost effective diagnosis of chromosome abnormalities http://www.medworm.com/index.php?rid=3250318&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00031 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250318 Mon, 08 Feb 2010 16:10:21 +0100 3250318 Prostate cancer costs considerable http://www.medworm.com/index.php?rid=3250317&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00030 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250317 Mon, 08 Feb 2010 16:10:21 +0100 3250317 Eplerenone appears cost effective in EPHESUS study http://www.medworm.com/index.php?rid=3250316&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00029 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250316 Mon, 08 Feb 2010 16:10:21 +0100 3250316 Orphan-drug designations in the US increased from 208 during 2000 to 2002, to 425 in 2006 to 2008 http://www.medworm.com/index.php?rid=3250315&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00028 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250315 Mon, 08 Feb 2010 16:10:21 +0100 3250315 Paroxetine reduces tamoxifen benefits http://www.medworm.com/index.php?rid=3250314&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00027 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250314 Mon, 08 Feb 2010 16:10:21 +0100 3250314 Strategy to rule out DVT early seems cost effective http://www.medworm.com/index.php?rid=3250313&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00026 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250313 Mon, 08 Feb 2010 16:10:21 +0100 3250313 Pre-exposure HIV prophylaxis: cost effective in MSM population http://www.medworm.com/index.php?rid=3250312&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00025 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250312 Mon, 08 Feb 2010 16:10:21 +0100 3250312 Physical exercise programme benefits elderly women http://www.medworm.com/index.php?rid=3250311&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00024 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250311 Mon, 08 Feb 2010 16:10:21 +0100 3250311 PET-CT scanning appears worthwhile for NSCLC http://www.medworm.com/index.php?rid=3250310&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00023 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250310 Mon, 08 Feb 2010 16:10:21 +0100 3250310 Expanded vaccination for bird flu worth the investment http://www.medworm.com/index.php?rid=3250309&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00022 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250309 Mon, 08 Feb 2010 16:10:21 +0100 3250309 Influenza vaccines economically justified in pregnancy http://www.medworm.com/index.php?rid=3250308&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00021 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250308 Mon, 08 Feb 2010 16:10:21 +0100 3250308 Etravirine cost effective for multidrug resistant HIV-1 http://www.medworm.com/index.php?rid=3250307&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00020 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250307 Mon, 08 Feb 2010 16:10:21 +0100 3250307 Enhanced monitoring reduces drug use for haemodialysis http://www.medworm.com/index.php?rid=3250306&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00019 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250306 Mon, 08 Feb 2010 16:10:21 +0100 3250306 Economic burden of osteoarthritis in the US http://www.medworm.com/index.php?rid=3250305&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00018 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250305 Mon, 08 Feb 2010 16:10:21 +0100 3250305 Adjuvant radiotherapy wasteful for low-risk breast cancer http://www.medworm.com/index.php?rid=3250304&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00017 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250304 Mon, 08 Feb 2010 16:10:21 +0100 3250304 Belgian analysis finds atorvastatin cost saving in T2DM patients http://www.medworm.com/index.php?rid=3250303&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00016 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250303 Mon, 08 Feb 2010 16:10:21 +0100 3250303 Data support use of rotavirus vax in world's poorest countries http://www.medworm.com/index.php?rid=3250302&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00015 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250302 Mon, 08 Feb 2010 16:10:21 +0100 3250302 Children do best on fluticasone propionate + salmeterol http://www.medworm.com/index.php?rid=3250301&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00014 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250301 Mon, 08 Feb 2010 16:10:21 +0100 3250301 Prevention of congenital syphilis cost effective in China http://www.medworm.com/index.php?rid=3250300&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00013 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250300 Mon, 08 Feb 2010 16:10:21 +0100 3250300 Deaths prevented with MCV4 vax outweigh Guillain-Barre risk http://www.medworm.com/index.php?rid=3250299&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00012 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250299 Mon, 08 Feb 2010 16:10:21 +0100 3250299 Prescribing for pneumonia does not match guidelines http://www.medworm.com/index.php?rid=3250298&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00011 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250298 Mon, 08 Feb 2010 16:10:21 +0100 3250298 Two combination regimens have been added in a recent update http://www.medworm.com/index.php?rid=3250297&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00010 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250297 Mon, 08 Feb 2010 16:10:21 +0100 3250297 Guidelines for gestational diabetes mellitus (GDM) vary considerably http://www.medworm.com/index.php?rid=3250296&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00009 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250296 Mon, 08 Feb 2010 16:10:21 +0100 3250296 Guidelines for the use of antithrombotic agents in patients undergoing endoscopy have been released http://www.medworm.com/index.php?rid=3250295&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00008 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250295 Mon, 08 Feb 2010 16:10:21 +0100 3250295 eGFR a wise biomarker for angina http://www.medworm.com/index.php?rid=3250294&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00007 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250294 Mon, 08 Feb 2010 16:10:21 +0100 3250294 US President Obama's proposed 2011 budget includes generic drug user fees http://www.medworm.com/index.php?rid=3250293&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00006 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250293 Mon, 08 Feb 2010 16:10:21 +0100 3250293 An update on H1N1 vaccine coverage in the US http://www.medworm.com/index.php?rid=3250292&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00005 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250292 Mon, 08 Feb 2010 16:10:21 +0100 3250292 Antiobesity prescriptions for youth on the rise http://www.medworm.com/index.php?rid=3250291&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00004 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250291 Mon, 08 Feb 2010 16:10:21 +0100 3250291 Venous thromboembolism guidelines may save 10 000 lives http://www.medworm.com/index.php?rid=3250290&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00003 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250290 Mon, 08 Feb 2010 16:10:21 +0100 3250290 Bill and Melinda Gates have pledged $US10 billion over the next 10 years to fund the development and delivery of vaccines. http://www.medworm.com/index.php?rid=3250289&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00002 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250289 Mon, 08 Feb 2010 16:10:21 +0100 3250289 Nationwide reduction in salt intake could save $US billions http://www.medworm.com/index.php?rid=3250288&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000596%2Fart00001 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3250288 Mon, 08 Feb 2010 02:06:10 +0100 3250288 Dimebon [dimebolin] is expected to achieve peak year sales of $1.5 billion http://www.medworm.com/index.php?rid=3204166&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00038 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204166 Mon, 25 Jan 2010 17:07:08 +0100 3204166 Despite a slowdown in the increase of healthcare costs, annual health spending in the US has reached $US2.3 trillion, or $7681 per person. http://www.medworm.com/index.php?rid=3204165&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00037 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204165 Mon, 25 Jan 2010 17:07:08 +0100 3204165 Ninety-eight percent of surveyed rheumatologists have indicated that they will prescribe Actemra [tocilizumab] for rheumatoid arthritis http://www.medworm.com/index.php?rid=3204164&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00036 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204164 Mon, 25 Jan 2010 17:07:08 +0100 3204164 Tumour necrosis factor- (TNF-) inhibitors, especially Humira [adalimumab] and Remicade [infliximab], are expected to dominate http://www.medworm.com/index.php?rid=3204163&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00035 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204163 Mon, 25 Jan 2010 17:07:08 +0100 3204163 The English Department of Health has set out proposals to increase the use of generics in primary care http://www.medworm.com/index.php?rid=3204162&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00034 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204162 Mon, 25 Jan 2010 17:07:08 +0100 3204162 GAO reports extraordinary price hikes on brandname drug products http://www.medworm.com/index.php?rid=3204161&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00033 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204161 Mon, 25 Jan 2010 17:07:08 +0100 3204161 Biopsy battle favours SLNB http://www.medworm.com/index.php?rid=3204160&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00032 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204160 Mon, 25 Jan 2010 17:07:08 +0100 3204160 Overactive bladder: does solifenacin improve QOL? http://www.medworm.com/index.php?rid=3204159&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00031 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204159 Mon, 25 Jan 2010 17:07:08 +0100 3204159 Lung cancer patients spend one-fifth of time in hospital http://www.medworm.com/index.php?rid=3204158&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00030 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204158 Mon, 25 Jan 2010 17:07:08 +0100 3204158 QuantiFERON TB Gold: cost-effective screening for TB http://www.medworm.com/index.php?rid=3204157&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00029 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204157 Mon, 25 Jan 2010 17:07:08 +0100 3204157 FDACM followed by lower antidepressant prescribing http://www.medworm.com/index.php?rid=3204156&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00028 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204156 Mon, 25 Jan 2010 17:07:08 +0100 3204156 Integrating ART into antenatal clinics doubles ART use http://www.medworm.com/index.php?rid=3204155&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00027 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204155 Mon, 25 Jan 2010 17:07:08 +0100 3204155 Inequalities persist in UK cancer care http://www.medworm.com/index.php?rid=3204154&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00026 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204154 Mon, 25 Jan 2010 17:07:08 +0100 3204154 New guidelines have been released by the Scottish Intercollegiate Guideline Network (SIGN) for Parkinson's disease. http://www.medworm.com/index.php?rid=3204153&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00025 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204153 Mon, 25 Jan 2010 17:07:08 +0100 3204153 Metabolic comorbidities add to burden of bipolar disorders http://www.medworm.com/index.php?rid=3204152&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00024 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204152 Mon, 25 Jan 2010 17:07:08 +0100 3204152 Facility-based AIDS care remains best use of scarce resources http://www.medworm.com/index.php?rid=3204151&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00023 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204151 Mon, 25 Jan 2010 17:07:08 +0100 3204151 Disparities in health outcomes for CF unexplained http://www.medworm.com/index.php?rid=3204150&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00022 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204150 Mon, 25 Jan 2010 17:07:08 +0100 3204150 Holding off dialysis pays off http://www.medworm.com/index.php?rid=3204149&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00021 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204149 Mon, 25 Jan 2010 17:07:08 +0100 3204149 High costs of revascularisation difficult to recoup http://www.medworm.com/index.php?rid=3204148&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00020 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204148 Mon, 25 Jan 2010 17:07:08 +0100 3204148 Dynamic life-cycle modelling: trastuzumab as an example http://www.medworm.com/index.php?rid=3204147&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00019 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204147 Mon, 25 Jan 2010 17:07:08 +0100 3204147 Some questionable prescribing practices appear common http://www.medworm.com/index.php?rid=3204146&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00018 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204146 Mon, 25 Jan 2010 17:07:08 +0100 3204146 Extremely preterm birth: higher costs, lower QOL at age 11 http://www.medworm.com/index.php?rid=3204145&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00017 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204145 Mon, 25 Jan 2010 17:07:08 +0100 3204145 Versatis vs pregabalin for postherpetic neuralgia http://www.medworm.com/index.php?rid=3204144&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00016 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204144 Mon, 25 Jan 2010 17:07:08 +0100 3204144 Cost effectiveness of intensive statin therapy remains debatable http://www.medworm.com/index.php?rid=3204143&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00015 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204143 Mon, 25 Jan 2010 17:07:08 +0100 3204143 COPD: community-based care moderately cost effective http://www.medworm.com/index.php?rid=3204142&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00014 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204142 Mon, 25 Jan 2010 17:07:08 +0100 3204142 PPI use in elderly patients: guidelines not adhered to http://www.medworm.com/index.php?rid=3204141&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00013 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204141 Mon, 25 Jan 2010 17:07:08 +0100 3204141 Costs rise for rheumatic disorders http://www.medworm.com/index.php?rid=3204140&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00012 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204140 Mon, 25 Jan 2010 17:07:08 +0100 3204140 Variations in cancer survival emphasise health service needs http://www.medworm.com/index.php?rid=3204139&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00011 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204139 Mon, 25 Jan 2010 17:07:08 +0100 3204139 The impact of safety concerns on antipsychotic use http://www.medworm.com/index.php?rid=3204138&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00010 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204138 Mon, 25 Jan 2010 17:07:08 +0100 3204138 Decrementally cost-effective innovations rare http://www.medworm.com/index.php?rid=3204137&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00009 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204137 Mon, 25 Jan 2010 17:07:08 +0100 3204137 The first clinical guidelines for lymphangioleiomyomatosis have been drawn up http://www.medworm.com/index.php?rid=3204136&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00008 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204136 Mon, 25 Jan 2010 17:07:08 +0100 3204136 Ciclosporin cheaper when branded http://www.medworm.com/index.php?rid=3204135&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00007 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204135 Mon, 25 Jan 2010 17:07:08 +0100 3204135 The US Senate passed its health reform bill on 24 December. http://www.medworm.com/index.php?rid=3204134&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00006 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204134 Mon, 25 Jan 2010 17:07:08 +0100 3204134 Is innovation really worth seeking? http://www.medworm.com/index.php?rid=3204133&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00005 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204133 Mon, 25 Jan 2010 17:07:08 +0100 3204133 Rituximab pays off long term http://www.medworm.com/index.php?rid=3204132&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00004 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204132 Mon, 25 Jan 2010 17:07:08 +0100 3204132 Evidence-based guidelines for managing patients with intra-abdominal infection have been updated http://www.medworm.com/index.php?rid=3204131&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00003 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204131 Mon, 25 Jan 2010 17:07:08 +0100 3204131 Pharma accused as countries offload H1N1 vaccines http://www.medworm.com/index.php?rid=3204130&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00002 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204130 Mon, 25 Jan 2010 17:07:08 +0100 3204130 Costs of taxanes, capecitabine, quantified for breast cancer http://www.medworm.com/index.php?rid=3204129&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000595%2Fart00001 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3204129 Mon, 25 Jan 2010 02:06:17 +0100 3204129 PricewaterhouseCoopers predicts that the US personalised medicines market will reach $452 billion by 2015. http://www.medworm.com/index.php?rid=3159211&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00039 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159211 Mon, 11 Jan 2010 16:09:06 +0100 3159211 The community-acquired pneumonia drug market is forecast to decline by more than 15% by 2018 http://www.medworm.com/index.php?rid=3159210&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00038 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159210 Mon, 11 Jan 2010 16:09:06 +0100 3159210 The UN's goal of a 90% reduction in measles mortality rate between 2000 and 2010 has been achieved in all WHO regions except South-East Asia. http://www.medworm.com/index.php?rid=3159209&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00037 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159209 Mon, 11 Jan 2010 16:09:06 +0100 3159209 The UK Health Department report that drug prices in the UK are the lowest in Europe. http://www.medworm.com/index.php?rid=3159208&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00036 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159208 Mon, 11 Jan 2010 16:09:06 +0100 3159208 Sales of drugs for atrial fibrillation are projected to grow from $790 million in 2008 to $6.1 billion by 2018 http://www.medworm.com/index.php?rid=3159207&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00035 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159207 Mon, 11 Jan 2010 16:09:06 +0100 3159207 Decision Resources predicts that the Brazilian type 2 diabetes mellitus drug market will double by 2013. http://www.medworm.com/index.php?rid=3159206&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00034 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159206 Mon, 11 Jan 2010 16:09:06 +0100 3159206 Worksite wellness intervention benefits outstrip costs http://www.medworm.com/index.php?rid=3159205&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00033 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159205 Mon, 11 Jan 2010 16:09:06 +0100 3159205 German system nicer than NICE's http://www.medworm.com/index.php?rid=3159204&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00032 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159204 Mon, 11 Jan 2010 16:09:06 +0100 3159204 A measure to allow US pharmacies and wholesalers to import prescription medications from overseas has been defeated in the Senate http://www.medworm.com/index.php?rid=3159203&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00031 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159203 Mon, 11 Jan 2010 16:09:06 +0100 3159203 A patent pool for HIV/AIDS medications is expected to start up in mid 2010 http://www.medworm.com/index.php?rid=3159202&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00030 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159202 Mon, 11 Jan 2010 16:09:06 +0100 3159202 Spending on HIV: no pattern between epidemic types http://www.medworm.com/index.php?rid=3159201&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00029 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159201 Mon, 11 Jan 2010 16:09:06 +0100 3159201 Multifamily psychoeducation appears cost saving http://www.medworm.com/index.php?rid=3159200&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00028 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159200 Mon, 11 Jan 2010 16:09:06 +0100 3159200 FOLFOX-4 most effective, expensive in colon cancer http://www.medworm.com/index.php?rid=3159199&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00027 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159199 Mon, 11 Jan 2010 16:09:06 +0100 3159199 Switch to acellular pertussis vaccine a good move http://www.medworm.com/index.php?rid=3159198&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00026 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159198 Mon, 11 Jan 2010 16:09:06 +0100 3159198 Self treatment of COPD exacerbations looks favourable http://www.medworm.com/index.php?rid=3159197&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00025 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159197 Mon, 11 Jan 2010 16:09:06 +0100 3159197 Hospitalisation rates drop since implementation of rotavirus vax http://www.medworm.com/index.php?rid=3159196&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00024 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159196 Mon, 11 Jan 2010 16:09:06 +0100 3159196 Cholinesterase inhibitor prescriptions soar in Germany http://www.medworm.com/index.php?rid=3159195&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00023 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159195 Mon, 11 Jan 2010 16:09:06 +0100 3159195 Cotrimoxazole defeats HAART in Eastern Uganda http://www.medworm.com/index.php?rid=3159194&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00022 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159194 Mon, 11 Jan 2010 16:09:06 +0100 3159194 Immunosuppressants: noncompliance ups graft-failure http://www.medworm.com/index.php?rid=3159193&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00021 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159193 Mon, 11 Jan 2010 16:09:06 +0100 3159193 Ertapenem does well for diabetic foot infections http://www.medworm.com/index.php?rid=3159192&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00020 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159192 Mon, 11 Jan 2010 16:09:06 +0100 3159192 Direct-to-consumer advertising bumps up clopidogrel prices http://www.medworm.com/index.php?rid=3159191&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00019 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159191 Mon, 11 Jan 2010 16:09:06 +0100 3159191 Warnings result in switch to typical antipsychotics http://www.medworm.com/index.php?rid=3159190&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00018 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159190 Mon, 11 Jan 2010 16:09:06 +0100 3159190 CAP costs lower with levofloxacin http://www.medworm.com/index.php?rid=3159189&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00017 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159189 Mon, 11 Jan 2010 16:09:06 +0100 3159189 Ultrafiltration unlikely to cost less than diuretics http://www.medworm.com/index.php?rid=3159188&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00016 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159188 Mon, 11 Jan 2010 16:09:06 +0100 3159188 Exenatide is associated with significantly lower medical costs than insulin glargine http://www.medworm.com/index.php?rid=3159187&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00015 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159187 Mon, 11 Jan 2010 16:09:06 +0100 3159187 Bladder cancer options weighed up http://www.medworm.com/index.php?rid=3159186&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00014 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159186 Mon, 11 Jan 2010 16:09:06 +0100 3159186 Greater hospital care results in fewer HF mortalities http://www.medworm.com/index.php?rid=3159185&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00013 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159185 Mon, 11 Jan 2010 16:09:06 +0100 3159185 Contraindicated medications commonly used for angioplasty http://www.medworm.com/index.php?rid=3159184&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00012 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159184 Mon, 11 Jan 2010 16:09:06 +0100 3159184 In pregnant women, universal serum screening for primary cytomegalovirus (CMV) infections is more cost effective http://www.medworm.com/index.php?rid=3159183&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00011 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159183 Mon, 11 Jan 2010 16:09:06 +0100 3159183 Activity against meticillin-resistant Staphylococcus aureus (MRSA) infections is a top factor influencing drug selection http://www.medworm.com/index.php?rid=3159182&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00010 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159182 Mon, 11 Jan 2010 16:09:06 +0100 3159182 Vaccine sales worth billions to ancillary markets http://www.medworm.com/index.php?rid=3159181&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00009 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159181 Mon, 11 Jan 2010 16:09:06 +0100 3159181 Since the year 2000, malaria prevalence has halved in a number of countries; http://www.medworm.com/index.php?rid=3159180&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00008 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159180 Mon, 11 Jan 2010 16:09:06 +0100 3159180 Guidelines updated for myocardial infarction and angioplasty http://www.medworm.com/index.php?rid=3159179&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00007 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159179 Mon, 11 Jan 2010 16:09:06 +0100 3159179 Avastin's market share threatened by novel agents' survival benefits http://www.medworm.com/index.php?rid=3159178&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00006 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159178 Mon, 11 Jan 2010 16:09:06 +0100 3159178 Seventy percent of pharmacy directors in the US expect to cover tanezumab if it is approved for the treatment of chronic pain http://www.medworm.com/index.php?rid=3159177&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00005 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159177 Mon, 11 Jan 2010 16:09:06 +0100 3159177 The US National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology have been updated to include Istodax (romidepsin) http://www.medworm.com/index.php?rid=3159176&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00004 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159176 Mon, 11 Jan 2010 16:09:06 +0100 3159176 ESC syncope guidelines updated http://www.medworm.com/index.php?rid=3159175&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00003 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159175 Mon, 11 Jan 2010 16:09:06 +0100 3159175 The 2009 Kidney Disease: Improving Global Outcomes clinical practice guidelines have been released http://www.medworm.com/index.php?rid=3159174&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2010%2F00000001%2F00000594%2Fart00002 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=3159174 Mon, 11 Jan 2010 16:09:06 +0100 3159174